Type 2 & other diabetes

Disease modification outcomes in type 2 diabetes: a modified Delphi

Lancet Diabetes EndocrinolPublished Modified Delphi consensus study

Study context

Population
Health-care professionals, researchers and patients; steering group of clinicians, researchers and people living with T2Dround one n=233
Outcome
Core outcome set for disease modification in T2D
Methodological detailsconducted according to COMET guidance, two Delphi rounds, international multidisciplinary steering group, Candidate outcomes identified from the literature and refined by the steering group
  • Conducted according to COMET guidance
  • Two Delphi rounds
  • International multidisciplinary steering group
  • Candidate outcomes identified from the literature and refined by the steering group

Recommendations

As reported in the abstract

Outcomes reaching agreement

35

Domains spanned

11

Original publication

Disease modification outcomes in type 2 diabetes: a modified Delphi. Lancet Diabetes Endocrinol. Published 29 September 2026. doi:10.1016/s2213-8587(26)00243-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.